Private Wealth Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.5M Buy
11,215
+727
+7% +$743K 1.3% 14
2026
Q1
$9.65M Buy
10,488
+119
+1% +$121K 1.03% 21
2025
Q4
$11.1M Sell
10,369
-88
-0.8% -$84.1K 1.21% 16
2025
Q3
$7.98M Sell
10,457
-524
-5% -$390K 0.94% 22
2025
Q2
$8.56M Sell
10,981
-46
-0.4% -$35.7K 1.14% 21
2025
Q1
$9.11M Buy
+11,027
New +$9.18M 1.31% 14

Other funds holding LLY

Private Wealth Asset Management's LLY Position: Q2 2026 in Review

Private Wealth Asset Management increased its Eli Lilly (LLY) stake by 6.9% in Q2 2026, buying an estimated $743K and bringing the position to 11,215 shares worth $13.5M. The position accounts for 1.3% of the portfolio, ranked #14.

Private Wealth Asset Management first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Private Wealth Asset Management held 11,215 shares of Eli Lilly worth $13.5M as of Q2 2026.
  • Private Wealth Asset Management bought 727 Eli Lilly shares in Q2 2026, an estimated $743K.
  • Eli Lilly made up 1.3% of Private Wealth Asset Management's portfolio in Q2 2026, its #14 holding.
  • Private Wealth Asset Management first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Private Wealth Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.